Fatal interruption of a 3TC-containing regimen in a HIV-infected patient due to re-activation of chronic hepatitis B virus infection.
Sellier
Pierre
P
Service de Médecine Interne A, Hôpital Lariboisière, Paris, France. pierre.sellier@lrb.ap-hop-paris.fr
Clevenbergh
Philippe
P
Mazeron
Marie-Christine
MC
Cazals-Hatem
Dominique
D
Evans
John
J
Cervoni
Jeanine
J
Badsi
Esma
E
Bendenoun
Marc
M
Diemer
Myriam
M
Vincent
Valerie
V
Caulin
Charles
C
Bergmann
Jean-Francois
JF
D019380:Anti-HIV Agents / Q000008:administration & dosage*; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D017809:Fatal Outcome; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy; D015497:HIV-1; D006515:Hepatitis B virus / Q000502:physiology*; D019694:Hepatitis B, Chronic / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D019259:Lamivudine / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage*; D014775:Virus Activation
D019380:Anti-HIV Agents; D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine